The use of adrenocorticotrophic hormone as a potential biomarker of pituitary pars intermedia dysfunction in horses.

This research explores the potential of using Adrenocorticotrophic hormone (ACTH) concentrations in the blood as an indicator of pituitary pars intermedia dysfunction (PPID) in horses, a condition that can increase their susceptibility to laminitis. The study found significant differences in ACTH levels between normal horses and those with PPID, suggesting that ACTH could be used as a reliable biomarker for this disorder.

Understanding the Study

• The primary purpose of the study was to investigate the link between plasma Adrenocorticotrophic hormone (ACTH) levels and pituitary pars intermedia dysfunction (PPID) in horses. PPID is a common hormonal disorder in aging horses that can lead to various health complications, including laminitis. The authors hypothesized that ACTH concentrations in the blood could be a potential biomarker for this condition.
• To test their hypothesis, the researchers compared the 24-hour plasma ACTH profiles of horses with PPID and those of matched control horses. These profiles were determined at four key points throughout the year: March, June, September, and December.
• The researchers observed significant differences in ACTH concentrations between the groups, regardless of the time of day or season. These differences persisted in all seasons and throughout the 24-hour cycle. Both groups of horses showed higher ACTH concentrations in September and December than in March and June. However, the changes were more pronounced in horses with PPID.
• The data also indicated a significant interaction between the body condition (control versus PPID) and the season of peak ACTH response. Moreover, significant phase-shift differences, or changes in the timing of peak ACTH concentration, were observed between June and September.
• The results suggest that ACTH can serve as a potential biomarker for equine PPID, providing that appropriate ‘cut-off’ values are used at different times of the year. These ‘cut-off’ values would represent the thresholds at which ACTH concentrations could be considered abnormal and indicative of PPID.

Implications of the Research

• The use of ACTH as a biomarker could improve the diagnosis and treatment of PPID in horses. Early detection of the disorder might help prevent its associated health complications, ultimately benefiting the welfare of affected horses.
• However, the study also highlights the need for further research to determine the appropriate ‘cut-off’ values for ACTH concentrations at different times of the year. These values would help in distinguishing normal ACTH fluctuations from those associated with PPID.
• The observed interaction between body condition and season suggests that these factors could influence ACTH responses in horses, a factor that needs to be taken into account when developing diagnostic protocols for PPID based on ACTH concentrations.